If Successful, HRA Pharma Acquisition Will Complete Perrigo’s Pivot Towards Self-Care

 
• By David Ridley

If its acquisition of France's HRA Pharma completes, Perrigo will have “enough growth in our back pocket for the next three to five years without making any further acquisitions,” says the firm’s UK & Ireland chief, Neil Lister, in an exclusive interview with HBW Insight. 

strategy concept - hands holding back-lit blue puzzle pieces coming together
• Source: Shutterstock

Perrigo Company plc’s recently announced acquisition of French consumer health company HRA Pharma will, if it goes through, complete the former’s pivot into a pure self-care player, according to the firm’s UK & Ireland chief Neil Lister.

Expected to close by the end of the first half of 2022, the €1.8bn ($2

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from International

More from Geography